Search references for AXA1125. Phrases containing AXA1125
See searches and references containing AXA1125!AXA1125
Experimental drug
AXA1125 is an experimental drug developed by Axcella Health that "increased β-oxidation and improved bioenergetics in preclinical models". It was studied
AXA1125
engineered probiotic against alcohol-induced damage (11 Apr), phase 2 trialed AXA1125 against long COVID fatigue (14 Apr), review finds cranberry products useful
2023_in_science
Investigational long COVID drugs
interrupted time-series study reporting symptom improvement [21] AXA-1125 (AXA1125) – combination of five amino acids (leucine, isoleucine, valine, arginine
List of investigational long COVID drugs
List_of_investigational_long_COVID_drugs
AXA1125
AXA1125
AXA1125
AXA1125
AXA1125
AXA1125
AXA1125
AXA1125
AXA1125